Details for New Drug Application (NDA): 073644
✉ Email this page to a colleague
NDA 073644 describes VIVACTIL, which is a drug marketed by Chartwell Rx and Teva Womens and is included in three NDAs. Additional details are available on the VIVACTIL profile page.
The generic ingredient in VIVACTIL is protriptyline hydrochloride. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the protriptyline hydrochloride profile page.
The generic ingredient in VIVACTIL is protriptyline hydrochloride. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the protriptyline hydrochloride profile page.
Summary for 073644
| Tradename: | VIVACTIL |
| Applicant: | Chartwell Rx |
| Ingredient: | protriptyline hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 073644
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Aug 24, 1995 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
